Compare IMVT & AN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMVT | AN |
|---|---|---|
| Founded | 2018 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 6.9B |
| IPO Year | 2019 | 1995 |
| Metric | IMVT | AN |
|---|---|---|
| Price | $41.82 | $208.98 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 9 |
| Target Price | $33.00 | ★ $244.33 |
| AVG Volume (30 Days) | ★ 963.7K | 407.7K |
| Earning Date | 05-28-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 0.71 |
| EPS | N/A | ★ 11.26 |
| Revenue | N/A | ★ $27,631,400,000.00 |
| Revenue This Year | N/A | $4.32 |
| Revenue Next Year | N/A | $2.89 |
| P/E Ratio | ★ N/A | $18.60 |
| Revenue Growth | N/A | ★ 3.24 |
| 52 Week Low | $14.47 | $176.62 |
| 52 Week High | $42.92 | $235.81 |
| Indicator | IMVT | AN |
|---|---|---|
| Relative Strength Index (RSI) | 62.62 | 52.30 |
| Support Level | $37.16 | $199.04 |
| Resistance Level | N/A | $214.55 |
| Average True Range (ATR) | 1.38 | 7.77 |
| MACD | 0.15 | -1.30 |
| Stochastic Oscillator | 80.46 | 34.11 |
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The Company operates in a single operating segment and has one reportable segment, which includes all activities related to the discovery, development and manufacturing of its product candidates.
AutoNation is the second-largest automotive dealer in the United States, with 2025 revenue of $27.6 billion and over 245 dealerships, plus 52 collision centers. The firm also has 24 AutoNation USA used-vehicle stores, a captive lender, four auction sites, and three parts distributors across 20 states primarily in Sunbelt metropolitan areas. New-vehicle sales account for nearly half of revenue; the company also sells used vehicles, parts, and repair services as well as auto financing. The company (formerly Republic Industries) divested its waste management unit (Republic Services) in 1999 and its car rental businesses (ANC Rental) in 2000. Wayne Huizenga founded the company in the 1990s to bring the rollup acquisition strategy to auto retailing, which proved to be a smart move.